MicroRNA-based signatures of early and late immune-related adverse events to anti-PD1 treatment.

Authors: Joanne B. Weidhaas, Kristen McGreevy, Alexandra Drakaki, Susan Ann McCloskey, Kelly Elizabeth McCann, Rena Desai Callahan, John A. Glaspy, Donatello Telesca

Published: 2025-05-28

DOI: 10.1200/jco.2025.43.16_suppl.2661

Source: Full article


Abstract

2661